Form D · Biotechnology
National Biopharma, LLC
Chesapeake, OH · CIK 0001701043
Offering snapshot reported Apr 28, 2017 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-285682
Source: Form D, filed Apr 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ken Carter | Director, Executive |
| Dakota Collins | Director, Executive |
| Linda Marshall | Director, Executive |
| Ken Mc Millian | Director, Executive |
| Michelle Renick | Executive |
| Kulvinder Somra | Director, Executive |
| Ric Widdifield | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
607 Third Avenue #745
Chesapeake, OH, 45619
Chesapeake, OH, 45619